Author

Yanchen Li

Lanzhou UniversityORCID 0000-0002-1405-5526Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yanchen Li1 paper · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Haixia ZhaoiD· 1 shared Jiaxi YaoiD· 1 shared Jingman NiiD· 1 shared Qiuxia ZhengiD· 1 shared Xuekai Hu· 1 shared Yue Zhang· 1 shared Yun Zhang· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Haixia ZhaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedJul 1, 2025

Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma

Xuekai Hu, Yue Zhang, Yanchen Li…·Jiaxi Yao

This study evaluates the efficacy of anticancer peptides in patient-derived organoids of intrahepatic cholangiocarcinoma, showing their potent anti-tumour effects through direct membrane disruption and apoptosis induction.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky